Histo-blood group antigens (HBGAs) may influence immune responses to rotavirus vaccination. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• May 2023

Improvements in neonatal critical care have resulted in more people than ever reaching adulthood after being born prematurely. At the same time, it is becoming clearer that preterm birth can increase the risk of respiratory disease throughout a person’s lifetime. Awareness that a patient was born preterm can enable early specialist assessment and intervention when there is any concern about lung health.  ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• September 2023

Intravascular tumor extension is an uncommon complication of solid malignancies that, when present in the inferior vena cava (IVC), can result in fatal pulmonary tumor embolism. Currently, neoadjuvant chemotherapy and surgery are the mainstays of treatment; however, there are no consensus guidelines for management.   ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• November 2023

The Toronto Paediatric Cancer Stage Guidelines are a compendium of staging systems developed to facilitate collection of consistent and comparable data on stage at diagnosis for childhood cancers by cancer registries. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• August 2023

Here we describe a method by which serial biopsy can be used to validate response to dacomitinib treatment in vivo using a mouse glioblastoma model ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2017
• April 2017

Fiona Stanley FJ FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD HonFRCPCH HonLLB (honoris causa) Patron 08 6319 1176 contact@telethonkids.org.au Patron Named Australian of the Year in 2003, Professor Fiona Stanley is a ...

• Telethon Kids Institute
• Our research
• Early Environment
• Developmental Origins of Child Health
• Expired projects

Medulloblastoma is the most common malignant childhood brain tumor, and 5-year overall survival rates are as low as 40% depending on molecular subtype, with new therapies critically important. As radiotherapy and chemotherapy act through the induction of DNA damage, the sensitization of cancer cells through the inhibition of DNA damage repair pathways is a potential therapeutic strategy. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• April 2021

Medulloblastoma, the most common pediatric malignant brain tumor, consists of at least four distinct molecular subgroups. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2015
• February 2015

HealthNuts is a single-centre, multi-wave, population-based longitudinal study designed to assess prevalence, determinants, natural history and allergy... ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2015
• January 2015

Brain tumors presenting in infancy, especially during the first 6 months of life. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2012
• September 2012

To determine the constellation of lifestyle and demographic factors that are associated with poor mental health in an adolescent population. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2011
• January 2011

With improvement in leukemia therapy, central nervous system (CNS) tumors are the leading cause of cancer mortality in children and the most expensive... ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2011
• January 2011